Elos Medtech – Annual Report and Sustainability Report for 2017 published

Elos Medtech AB’s Swedish language Annual Report for 2017, as well as the English language Sustainability Report for 2017, have today been published on our website, www.elosmedtech.com

The Annual Report for 2017 can be found under IR and Financial reports. The Sustainability Report for 2017 is published under About Us and Sustainability.

In the report, Elos Medtech clarifies its responsibilities for sustainability and highlights the year’s most important initiatives in connection with the first publication of its Sustainability Report in 2017. This means, among other things, that the reader is primarily referred to the online version of both the Annual Report and Sustainability Report for 2017. In doing so, we have made a significant reduction to the number of printed copies of the reports, thereby increasing our contribution to a more sustainable environment.

Gothenburg, April 3, 2018

Elos Medtech AB (publ)

For further information, please contact: Jan Wahlström, President and CEO, +46 70 212 18 89, jan.wahlstrom@elosmedtech.com or Christian Bergaust, CFO, +46 70 293 50 40, christian.bergaust@elosmedtech.com


For further information about the Elos Medtech Group, please refer to www.elosmedtech.com

This information in this report is information that Elos Medtech AB (publ) is required to publish under the EU Market Abuse Regulation. The information was submitted (by the contact person specified above) for publication on April 3, 2018 at 15:00 (CET).

Tags:

About Us

Elos Medtech is one of Europe's leading development and production partners for medical technology products and components, such as dental and orthopaedic implants and instruments. The operations are conducted at facilities in Sweden, Denmark, China and USA. Customers are mainly internationally active medical technology companies in the market segments Dental Implant Systems, Diagnostics, Medical Devices and Trauma & Spine. Elos Medtech employs more than 500 people worldwide and generates revenue that exceeds MSEK 550. Elos Medtech has been traded on NASDAQ Stockholm AB since 1989. The Elos Medtech B share is classified as a Health Care company on the Small Cap list.